Sachs Associates would like to say we enjoyed hosting you at our 9th Annual Neuroscience Innovation Forum (#Sachs_NIF). We would like to thank those who joined us in-person in San Francisco and those who participated virtually. A special thank you goes to the excellent lineup of sponsors, chairs, panellists, and presenters who made such a broad and interesting programme possible.
Once again, the forum demonstrated its strong value to the neuroscience community, with over 440 participants from 22 countries registered and a record number of in-person attendees.
We look forward to welcoming you again to our future events!
CONTRIBUTING SPONSOR:
Presenting Companies Included:
Confirmed Keynote Speakers Included:
Brian Fiske
Chief Scientific Officer, The Michael J. Fox Foundation for Parkinson's Research
Harry Tracy
President, NI Research Inc.
Jonathan Javitt
CEO, NRx Pharmaceuticals, Inc.
Speakers and Chairs Included:
Bruce Leuchter
President & CEO, Neurvati Neurosciences, Inc.
Carla Lema Tomé
Executive Director Business Development, Head of US BD, Otsuka Pharmaceutical Co., Ltd.
Daniel Lee
Partner, PJT Partners
Diana Saraceni
Co-Founder & General Partner, Panakès Partners SGR SpA
Ginger Johnson
SVP, Neuroscience Lead, Lumanity
Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.
Jeffrey Cohen
Director of Research, Ladenburg Thalmann & Co. Inc.
Joel Sandler
Associate Partner, Ipsos Healthcare Advisory Service
Manuel López-Figueroa
Scientific Liaison, Pritzker Neuropsychiatric Disorders Research Consortium
Murali Gopalakrishnan
Global Head, Neuroscience Search & Evaluation, Corporate Strategy Office, AbbVie, Inc.
Steve Dickman
CEO, CBT Advisors
Sumant Kulkarni
Managing Director, Biotechnology Equity Research, Canaccord Genuity LLC
Thomas Shrader
Managing Director & Healthcare Analyst, BTIG, LLC
Alexander Gebauer
Co-Founder & Executive Chairman, Galimedix Therapeutics, Inc.
Amit Etkin
Founder & CEO, Alto Neuroscience Inc.
Andrea Chicca
Co-Founder & CEO, Synendos Therapeutics AG
Anthony Caggiano
Chief Medical Officer, Cognition Therapeutics, Inc.
Arno de Wilde
Managing Director, EQT Life Sciences
Carlos Buesa
Founder & CEO, Oryzon Genomics, S.A.
Cassandra Snipes
Senior Director Scientific Innovations, Click Therapeutics, Inc.
Celine Bouquet
Neuroscience, Ophthalmology & Rare Diseases Pharma Partnering Site Head Basel, F. Hoffmann-La Roche Ltd.
Chris Witowski
Co-Founder & CEO, Psilera Inc.
Christos Papadimitriou
Co-Founder & CEO, Tessara Therapeutics Pty Ltd.
Derek Small
Founding CEO, Luson Bioventures
Eric Snyder
Partner, Novo Holdings US Inc.
Gaia Skibinski
Director of Discovery & Translational Research, The Michael J. Fox Foundation for Parkinson's Research
Gene Mack
President & CEO, Gain Therapeutics, Inc.
Greg Mayes
President & CEO, Reunion Neuroscience, Inc.
Gregor Macdonald
VP, Head of BD & Licensing, Search & Assessment, H. Lundbeck A/S
Hugh Nuthall
Executive Director, Search & Evaluation Neuroscience, Eli Lilly and Company
James Cavuoto
Editor & Publisher, Neurotech Reports
Jonathan Behr
Partner, Dementia Discovery Fund, an SV Health Investors, LLC Fund
Joseph Tucker
CEO, Enveric BioSciences, Inc.
Justin Hanka
Co-Founder & CEO, MindBio Therapeutics
Kabir Nath
CEO, Compass Pathways
Karen Harris
CFO & Head of Mission Related Investments, Alzheimer's Drug Discovery Foundation
Ken Mariash
CEO, Sinaptica Therapeutics, Inc.
Laura Ripin
VP, Head BD&L Transactions Neuroscience, Novartis Pharma AG
Lynn Durham
Founder & CEO, STALICLA SA
Mankit Law
Senior Director, BD, Search & Evaluation, GSK
Mark Rus
President & CEO, Delix Therapeutics, Inc.
Nick Manusos
CEO, Kenai Therapeutics
Paolo Di Giorgio
Managing Director & CEO, Angelini Ventures S.p.A.
Rotem Kopel
CEO, ABILITY Neurotech
Samantha Murphy
Vice President, Corporate Development, Aspen Neuroscience, Inc.
Sarah Kleinpeter
SVP, Head of Alzheimer's & Dementia Franchise, Biogen
Seth Lederman
Chairman & CEO, Tonix Pharmaceuticals Holding Corp.
Spring Behrouz
CEO, Vincere Biosciences Inc.
Srinivas Rao
Co-Founder & CEO, AtaiBeckley
Stefan König
CEO, Merz Therapeutics GmbH
Yury Kukushkin
Investment Partner, Hevolution